Megan Deacon-Casey, MD
Vascular & Interventional Radiology · Ponte Vedra Beach, FLNPI 1235112517
Payments from drug & device makers
What this record shows
The money is spread across several categories — other (54.8%), education and food and beverage — rather than concentrated in one kind of arrangement. Angiodynamics, Inc. accounts for 72.5% of it on its own, with 10 other manufacturers making up the rest. 2025 is the largest year on record at $8,221, 3.7 times the $2,237 reported in 2019.
Across 163 payments — averaging $156.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Angiodynamics, Inc.$19K
- Medtronic$4K
- Galderma Laboratories, L.p.$989
- Merz North America, Inc.$926
- AbbVie$828
- Bard Peripheral Vascular, Inc.$312
- plus $401 from 5 others
What the payments were for
- Speaking & faculty fees$2,80011%
- Food & beverage$4,34217%
- Education$4,40017%
- Other$14,01055%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Angiodynamics, Inc. | 16 | $18,531 |
| Medtronic | 20 | $3,565 |
| Galderma Laboratories, L.p. | 47 | $989 |
| Merz North America, Inc. | 15 | $926 |
| AbbVie(2 entities) | 46 | $828 |
| Bard Peripheral Vascular, Inc. | 6 | $312 |
| Revance Therapeutics, Inc. | 4 | $183 |
| Boston Scientific | 5 | $104 |
| Venclose Inc. | 1 | $65 |
| Cashflow Solutions, LLC | 2 | $31 |
| Team 1, LLC | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VenaCure 1470 Pro$15,210
- EVLT$3,200
- VenaSeal$2,800
- XEOMIN$233
- ClosureFast$128
- Venclose Maven Catheter$128
How this compares
$25,552 in reported general payments places this provider in the 80th percentile of 329 vascular & interventional radiology providers in Florida.
See all vascular & interventional radiology providers in Florida →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ondansetron OdtOndansetron | 12 | $130 |
Paid to pharmacies, not to this prescriber.
Other vascular & interventional radiology in Ponte Vedra Beach
- Paul VitulliPonte Vedra Beach$63K
- Ripal GandhiMiami$2.5M
- Michael CohnHollywood$1.3M
- Bret WiechmannGainesville$1.3M
- George OliveiraMiami$666K
- Fakhir ElmasriLakeland$563K
- Shaun PatelCoral Gables$458K
- Justin LeeTampa$408K
- Timothy YatesMiami Beach$392K
- Rishi RazdanJacksonville$378K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.